Pre-exposure prophylaxis (PrEP) is provided free of costs to Introduction: at-risk populations in Kenya, including men who have sex with men (MSM), but anal intercourse is not an eligibility criterion. We set out to determine PrEP eligibility, uptake and predictors of PrEP uptake among MSM enrolled in an HIV-1 vaccine feasibility cohort in coastal Kenya.
Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine has been recommended for use in prevention of HIV-1 acquisition 1 . In response, several countries have implemented country-specific policies and guidelines on PrEP delivery, uptake and monitoring, and a few have made PrEP available nationally to the public 2, 3 . In Kenya, national PrEP roll-out began in May 2017 after the Ministry of Health (MoH) included guidance on offering PrEP to HIV-1 negative individuals at substantial ongoing risk of HIV-1 acquisition 4 . These guidelines, which include several indications to guide PrEP eligibility and initiation among sexually active HIV-1 negative individuals, do not specifically mention receptive anal intercourse (RAI). Despite this gap, men who have sex with men (MSM) are a key population targeted for PrEP 5, 6 .
In 2017, we developed an empiric risk score to guide PrEP targeting among at-risk MSM who were followed in a vaccine feasibility study and had an HIV-1 incidence of 7.0 (95% confidence interval [CI], 5.8-8.6) per 100 person-years. Characteristics of the cohort-derived HIV-1 risk score (CDHRS) included having only male sex partners, RAI, any recent unprotected sex, group sex, and young age (18-24 years) 7 . Although the CDHRS tool demonstrated good performance in detecting HIV-1 acquisition among MSM eligible for PrEP in this cohort, we were interested in comparing it to the performance of the MoH PrEP risk criteria to identify at-risk MSM for PrEP uptake in this cohort.
We therefore assessed: 1) performance of the MoH guideline criteria to predict HIV-1 acquisition in at-risk MSM using the historic cohort, 2) eligibility for PrEP by either MoH or CDHRS in the cohort since PrEP programming started in June 2017, and 3) PrEP uptake and factors associated with PrEP uptake among MSM eligible for PrEP who were followed in a HIV-1 vaccine feasibility cohort study in coastal Kenya.
Methods

Study population
Since July 2005, individuals at high risk for HIV-1 acquisition have been recruited for an open cohort study in preparation for a HIV-1 vaccine efficacy trial in a Kenya Medical Research Institute (KEMRI) clinic in Mtwapa town, coastal Kenya. This town, approximately 20 kilometers north of Mombasa, is known for its busy night life and many bars and nightclubs, which are frequented by sex workers 8 . Participants were identified for recruitment into the study by 10-15 trained peer mobilizers who approached individuals through personal networks and at venues where sex workers meet to establish contact with clients 9 . Adults aged 18-49 years were eligible if they met any of the following criteria: HIV-1-negative and reporting any of transactional sex work, a recent sexually transmitted infection (STI), multiple sexual partners, sex with an HIV-1-infected partner, or anal sex during the 3 months before enrolment 9 .
Cohort procedures
Detailed cohort procedures have been described elsewhere 9,10 . In brief, during enrollment and monthly follow-up visits, a face-to-face interview using a standardized risk behaviour questionnaire, HIV-1 testing and counseling using rapid point of care antibody tests, risk-reduction counselling, medical history and physical examination were performed. Preparing MSM for PrEP uptake Between January-June 2017, we offered standardized educational messages to cohort participants on benefits, risks, eligibility and upcoming availability of daily PrEP during individual discussions with clinicians at follow-up visits. In addition, weekly group educational sessions led by counselors were provided to cohort participants who had expressed interest in learning about PrEP. In both individual and group sessions, we educated participants about known predictors of HIV-1 acquisition among MSM in our cohort, including RAI, group sex, any recent unprotected sex, having sex with men only and gonorrhea infection within the past six months 9 . Because younger age (18-24 years) had become an additional independent predictor in our cohort 7 , we explained to individuals in this age group their higher risk. Using these identified risk factors in the CDHRS and additional MoH PrEP eligibility criteria 3 , we designed an individualized PrEP eligibility score sheet based on risks reported during the previous three months to target PrEP counseling (see extended data 11 ).
PrEP rollout
Since June 2017, PrEP has been offered to eligible cohort participants in follow-up. Participants were evaluated for PrEP eligibility at enrollment and monthly follow-up visits during risk reduction counselling sessions by counselors. Those who were eligible by either CDHRS or MOH criteria according to the PrEP Eligibility Score Sheet (see extended data 11 ) were offered PrEP, and their renal function (i.e. creatinine), hepatitis B surface antigen (HBsAg), and symptoms of acute HIV-1 infection (AHI) assessed according to the Kenyan MoH PrEP guidelines 3 . Participants who tested positive for HBsAg were offered PrEP with close monitoring of liver function while those who tested negative were vaccinated against hepatitis B infection 10 . Participants who had symptoms compatible with AHI, or those meeting specific risk criteria that increased their risk of HIV-1 acquisition (e.g. RAI, or group sex) were tested for HIV-1 RNA (Xpert® HIV-1 Qual, Cepheid) to rule out AHI prior to PrEP initiation. Participants with no contraindication to PrEP were counselled about the risks, benefits and limitations of PrEP, educated about recognizing AHI symptoms, and provided with a 30-day PrEP supply. Individuals who had previously taken PrEP through other organisations were invited to transfer to KEMRI PrEP programme if they so desired.
During monthly follow-up visits, participants not taking PrEP were reassessed for eligibility and offered PrEP if eligible. Participants taking PrEP completed a computer-assisted selfinterview to assess PrEP adherence and motivation to continue PrEP and were monitored for adverse effects, offered syndromic STI treatment as clinically indicated, and tested for HIV-1 (see extended data 11 ). PrEP adherence and sexual risk reduction counseling were provided prior to PrEP refill. Participants with symptoms or signs compatible with AHI were tested for HIV-1 RNA as described above. Participants who tested HIV-1-positive (either on RNA or rapid antibodies) had PrEP discontinued and were counselled and linked to HIV-1 care and treatment.
Measures CDHRS eligibility. This variable was defined as having any of the following risk factors at any visit, categorized as either yes or no: age 18-24 years, having only male sex partners, RAI, any recent unprotected sex, and group sex. Individuals who had any of these risk factors in the 3 months before screening were considered eligible for PrEP by CDHRS criteria.
MoH eligibility. This variable was defined as having any of the following characteristics per MoH PrEP guidelines 3 at any visit, categorized as either yes or no: sex with a regular partner of known HIV-1-positive or unknown HIV-1 status in the past week, sex with any partner of known HIV-1-positive or unknown HIV-1 status in the past month, transactional sex (defined as receiving payment for sex with cash, living expenses, or goods) in the past 3 months, sharing needles among intravenous drug users in the past 3 months, sex after alcohol use in the past month, recurrent use of post-exposure prophylaxis (PEP, defined as PEP use more than once in the past 6 months), inconsistent condom use in the past week and recent STI (defined as a positive gram stain of urethral or rectal secretions or a new syphilis diagnosis within 6 months). Individuals who had any of these characteristics were considered eligible for PrEP by MOH criteria.
Other variables collected at each monthly visit on standardized risk behaviour questionnaire were evaluated as potential predictors of PrEP uptake included the number of reported sexual partners in the past week; paying for sex with cash, living expenses, or goods in the past 3 months; and demographic data collected at enrollment (e.g., education, religion, marital and employment status).
Data analysis and statistical methods
Historic cohort 2005-2016
Predicting HIV-1 acquisition. We censored data for each participant at the end of 2016, at the last visit (for those lost to follow-up) or at the last seronegative and HIV-1-RNA-negative visit (for those who acquired HIV-1 infection during follow-up). We obtained total observation time for all participants in the study by adding up separate observation times and expressing these in terms of pre-PrEP person-years. To assess the performance of the MoH criteria to identify MSM at risk of HIV-1 acquisition in the historic cohort (2005-2016), we assigned a score of one point to each characteristic (described above) reported and summed these scores to generate a total MoH score for each participant visit. A score of one point was assigned to each characteristic of the CDHRS and a total score was calculated for each visit, following published methodology 7 . We assessed sensitivity, specificity and area under the receiver operator characteristic (ROC) curve (AUC) for the MoH and CDHRS eligibility criteria using a non-parametric ROC analysis. We compared the AUC for the CDHRS eligibility score to the AUC for the MoH eligibility score using a test of equality of ROC areas.
PrEP cohort June-December 2017 Data collection. Risk behaviour questionnaire, laboratory results, medical history and physical examination data were entered into a secure database. Data were cleaned, recoded and analyzed using Stata 15.0 (StataCorp LP, College Station, TX).
PrEP eligibility and uptake. PrEP provision in limited programmes targeting key populations began in the area around January 2017. Because we did not have reliable data on PrEP use from outside programs, we excluded data collected in the period between January-May 2017. PrEP became available to the KEMRI cohort in June 2017. PrEP baseline was defined as the first study visit by a given participant during June-December 2017. PrEP uptake was defined as acceptance of PrEP by an eligible participant. We censored data for each participant at the end of 2017, at the last visit (for those lost to follow-up) or at the last seronegative and HIV-1-RNA-negative visit (for those who acquired HIV-1 infection during follow-up). Nine MSM who had started PrEP through another program were excluded. We calculated the number and proportion of MSM eligible by MoH vs. CDHRS criteria at PrEP baseline and presented the results using a Venn diagram. We then compared the proportion of MSM eligible for PrEP by each criterion at baseline and at the last visit in 2017 using McNemar's test for paired proportions, to determine consistency of PrEP eligibility over time.
We used descriptive statistics to compare baseline demographic and behavioural characteristics of eligible men who accepted PrEP at baseline to eligible men who did not accept PrEP at first offer. We then used generalized linear modeling with log link Poisson regression and robust error variance to identify factors independently associated with PrEP uptake at baseline. Potential predictors of PrEP uptake significant in bivariable analysis at P ≤ 0.2 were included in multivariable modeling. P values were 2-sided, and significance was set at P ≤ 0.05.
Ethical considerations
The KEMRI Ethics Review Committee approved the study (SSC 894). All participants provided written informed consent.
Results
Predicting HIV-1 acquisition From 2005-2016, HIV-1 incidence was 7.0 (95% CI, 5. Figure 3 ).
Men who declined PrEP at first offer were more likely to report having only female sex partners (6.1% vs. 0.0%, P=0.027), less likely to report RAI (65.3% vs. 81.4%, P=0.026) and less likely to have paid for sex (8.2% vs. 21.2%, P=0.043) in the past 3 months (Table 1) .
In bivariable modeling, PrEP acceptance at first offer was associated at P≤ 0.2 with being younger (18-24 years), never married, self-employed, reporting any recent unprotected sex, two or more sexual partners, RAI, having paid for sex, receiving payment for sex and group sex. In multivariable modeling, PrEP uptake was higher for men reporting RAI (adjusted prevalence ratio [aPR], 1.4; 95% CI, 1.0-1.9), men reporting having paid for sex (aPR, 1.3; 95% CI, 1.1-1.6) and men reporting group sex (aPR, 1.4; 95% CI, 1.1-1.8), after adjustment for age, marital status, and employment status. Reporting any recent unprotected sex, the number of reported sexual partners, and receiving payment for sex were not associated with PrEP uptake ( Table 2) .
None of the 167 MSM who were offered PrEP acquired HIV-1 in the period June-December 2017.
Discussion
We showed that among at-risk MSM followed in a historic cohort in the period 2005-2016, MoH criteria for PrEP eligibility were sub-optimal in targeting MSM at risk of HIV-1 acquisition, mainly due to the failure to include RAI as a PrEP eligibility criterion. When programmatic PrEP was offered to eligible MSM cohort participants using the CDHRS, 20% more at-risk MSM were identified for PrEP initiation than when MoH criteria were used. In our setting, 70% of the MSM accepted PrEP at first offer, and uptake was associated with reporting RAI and group sex, suggesting that PrEP is acceptable among high-risk MSM in Kenya. Of interest is the association of paying for sex with PrEP uptake, as this is not an eligibility criterion included in either the MoH or in our CDHRS tool. While these men met other PrEP eligibility criteria, it could be that paying for sex increases the perception of risk for HIV-1 acquisition among Kenyan MSM.
The fact that the MoH criteria did not identify MSM at risk for HIV-1 among the historic cohort was expected because risk behaviours (e.g., RAI and group sex) 7, 9, 12, 13 and sociodemographic factors (i.e., young age) 7 In the MoH guidelines, healthcare providers are required to assess and discuss HIV-1 acquisition risk without judgment 3, 16 . As adult male same-sex behaviour is illegal in Kenya and stigma towards MSM is pervasive in health care settings 17,18 , many providers may not feel comfortable asking men about same-sex partners or anal sex, leading to missed opportunities for PrEP provision. Moreover, although RAI is also practiced by women, HIV-1 acquisition risk due to RAI in women is underappreciated 19, 20 . If the Kenyan MoH PrEP guidelines can be updated to include RAI as an indicator for PrEP eligibility, this would help normalize discussions on anal sex and ensure that all individuals at high risk for HIV-1 acquisition are offered PrEP. In addition, sensitization training of health care providers should be facilitated to reduce homophobic attitudes 21 and improve MSM healthcare services 22 .
We report a relatively high PrEP uptake at first offer (70%) among eligible MSM in our study, with higher uptake among those who reported RAI, group sex or paying for sex. Although RAI and group sex were part of the CDHRS criteria for PrEP eligibility in our cohort 7 , paying for sex has not been found to be a risk factor for HIV-1 infection in our cohort. In the new MOH 'HIV self risk checker' -a rapid tool to assess PrEP eligibility (extended data 11 )-a question is included on receiving money or favors in exchange for sex: "Have you engaged in: sex in exchange for money or other favors". Arguably, a person paying for sex may say so, although a question on payment for sex would be preferred. Of note, the question in our risk assessment questionnaire captures payment for sex without specifying whether a male or female partner was paid. Asking men whether they have paid for sex may be one way to identify men who engage in other high-risk sexual behaviors, without pressuring them to admit to male-male sex.
With respect to the uptake rate of PrEP in our study, our findings are consistent with results documented in other settings in which PrEP uptake ranged between 60% and 93% 23-25 among MSM reporting condomless RAI 24 or condomless anal sex 26 . Although we did not find significant differences in PrEP eligibility at baseline compared to the end of the follow-up period in our study, four men became eligible during follow-up, highlighting the importance of period reassessments of HIV risk. We did not encourage men to discontinue PrEP if they no longer met criteria at a follow-up assessment, as we assumed that risk in our cohort would remain substantial.
About a third of the eligible MSM participants did not accept PrEP when it was first offered. Of note, 1 in 5 of these men accepted PrEP later in follow-up after the initial refusal. Upon review of their counseling records at baseline, the majority of men who delayed PrEP initiation reported that they were not ready to start. Others opted to continue using condoms, after considering the risks and benefits of PrEP. Further research to understand barriers and facilitators of PrEP uptake among MSM is needed, to target optimal interventions supporting PrEP uptake and adherence among MSM at high risk of HIV-1 acquisition in Kenya 27 .
Our study had several limitations. First, we did not collect data on partnerships, and so did not establish if any MSM was in a serodiscordant relationship and if so, whether the partner had achieved virologic suppression. Secondly, behavior risk assessment for PrEP initiation was conducted by trained staff with experience in assessing HIV-1 acquisition risks. Therefore, this risk assessment may not reflect risk assessment conducted in non-research settings providing PrEP services in Kenya, and uptake of PrEP by MSM at non-research settings may be lower. Thirdly, in our study, MSM were offered PrEP following a period of counselling on risks and benefits and the importance of PrEP adherence prior to PrEP availability, which may have enhanced uptake once the roll-out occurred. Lastly, our participants were in monthly follow-up, while national programmes recommend 3-montly visits for PrEP maintenance. The intensive counseling provided during monthly visits likely facilitated higher uptake of PrEP among MSM in our cohort.
Conclusions
Assessing PrEP eligibility in an HIV-1 vaccine feasibility cohort study of high-risk MSM using a CDHRS identified 20% more at-risk MSM for PrEP initiation than when MoH criteria were used. About 70% accepted PrEP at first offer, suggesting PrEP is acceptable among MSM reporting high-risk behavior. Consideration should be given to incorporating established risk factors for HIV-1 acquisition among MSM, especially RAI and group sex, into MoH guidelines, to enhance impact of PrEP programming among MSM and other key populations in Kenya. Our results show that men at high risk are interested in PrEP and that men who pay for sex are also interested in this HIV prevention intervention.
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